 inhibition proteoglycan synthesis human articular cartilage Cartilage normal controls patients osteoarthritis patients rheumatoid arthritis culture massive production ng/ml cartilage sources dose-dependent manner cases peak value levels induced similar rheumatoid arthritis synovial fluid concentrations complete inhibition proteoglycan PG synthesis production Exogenous PG synthesis inhibition PG synthesis antibodies recombinant human results inhibition PG synthesis